Abstract
The global diagnostics market is undergoing radical change; novel technologies
driven by miniaturization and advances in genomics will enhance the role of
diagnostics in the healthcare market, allowing more tests to be performed at
the point-of-care and facilitating the shift towards personalized medicine.
"Innovation in Diagnostics" examines the advances in the rapidly growing field
of molecular technologies that are enabling personalized healthcare to move
into mainstream medicine. New opportunities in infectious disease testing,
molecular oncology and pharmacogenomics are explored in detail, enabling you
to understand the forces that are driving in vitro diagnostics (IVDs) into
centre stage of the healthcare arena. Understand the changing relationship
between IVD companies and the pharmaceutical industry, assess the convergence
of IVDs and medical imaging, and develop an understanding of new technologies
that will influence diagnostic product development and drug development
programs.
View Cart
